drugset / Trial / NCT05016947
Venetoclax Plus Inotuzumab for B-ALL
NaSingle-groupOpen-labelTreatment
Summary
This research study is evaluating the safety and efficacy of administering venetoclax and inotuzumab ozogamicin in combination in patients with acute lymphoblastic leukemia (ALL) The names of the study drugs involved in this study are: * Venetoclax * Inotuzumab ozogamicin * Dexamethasone
Timeline
- Start
- 2021-09-24
- Primary completion
- 2023-07-10
- Completion
- 2026-12-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexamethasone | Small molecule | — | Oral |
| Subject | Inotuzumab Ozogamicin | Monoclonal antibody | — | Intravenous |
| Subject | Venetoclax | Small molecule | — | Oral |